These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 27783990)
1. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth. Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410. Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093 [TBL] [Abstract][Full Text] [Related]
3. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis. Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway. Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296 [TBL] [Abstract][Full Text] [Related]
5. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients. Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566 [TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629 [TBL] [Abstract][Full Text] [Related]
7. The role of transcriptional coactivator TAZ in gliomas. Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783 [TBL] [Abstract][Full Text] [Related]
8. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells. Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219 [TBL] [Abstract][Full Text] [Related]
9. The expressions of Wnt/β-catenin pathway-related components in brainstem gliomas. Wu W; Tian Y; Wan H; Song Y; Li J; Zhang L Can J Neurol Sci; 2013 May; 40(3):355-60. PubMed ID: 23603171 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of TET1 Promotes Glioma Cell Proliferation and Invasion by Targeting Wnt/ Ji J; You Q; Zhang J; Wang Y; Cheng J; Huang X; Zhang Y Anal Cell Pathol (Amst); 2021; 2021():8980711. PubMed ID: 34926132 [TBL] [Abstract][Full Text] [Related]
11. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis. Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901 [TBL] [Abstract][Full Text] [Related]
12. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation. Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117 [TBL] [Abstract][Full Text] [Related]
13. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway. Yu X; Wang M; Wu J; Han Q; Zhang X J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485 [TBL] [Abstract][Full Text] [Related]
14. Presenilin1 exerts antiproliferative effects by repressing the Wnt/β-catenin pathway in glioblastoma. Yang W; Wu PF; Ma JX; Liao MJ; Xu LS; Xu MH; Yi L Cell Commun Signal; 2020 Feb; 18(1):22. PubMed ID: 32046730 [TBL] [Abstract][Full Text] [Related]
15. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1. Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036 [TBL] [Abstract][Full Text] [Related]
16. PAX3 Promotes Proliferation of Human Glioma Cells by WNT/β-Catenin Signaling Pathways. Liang X; Dong Z; Bin W; Dekang N; Xuhang Z; Shuyuan Z; Liwen L; Kai J; Caixing S J Mol Neurosci; 2019 May; 68(1):66-77. PubMed ID: 30826985 [TBL] [Abstract][Full Text] [Related]
17. β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer. Ouyang W; Zhang S; Yang B; Yang C; Zhang J; Zhou F; Xie C Oncol Rep; 2016 Feb; 35(2):717-24. PubMed ID: 26717875 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA Linc00320 inhibits glioma cell proliferation through restraining Wnt/β-catenin signaling. Tian S; Liu W; Pan Y; Zhan S Biochem Biophys Res Commun; 2019 Jan; 508(2):458-464. PubMed ID: 30503496 [TBL] [Abstract][Full Text] [Related]
19. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer. Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283 [TBL] [Abstract][Full Text] [Related]
20. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]